concizumab

Novo Nordisk A/S: Phase 3 data for concizumab show 86% reduction in treated bleeds in haemophilia A or B with inhibitors
Yahoo Finance
Sun, 07/10/22 - 11:51 pm
Novo Nordisk
concizumab
hemophilia
Novo gets PhIII hemophilia trials for a Roche rival back on track after completing work-around on blood clot threat
Endpoints
Thu, 08/13/20 - 09:48 am
Novo Nordisk
hemophilia
concizumab
clinical trials
Novo Nordisk Pauses 3 Clinical Trials Testing Hemophilia Therapy
Xconomy
Mon, 03/16/20 - 11:50 pm
Novo Nordisk
clinical trials
concizumab
hemophilia